A pH-dependent anti-CD47 antibody that selectively targets solid tumors and improves therapeutic efficacy and safety.
Li Y, Liu J, Chen W, Wang W, Yang F, Liu X, Sheng Y, Du K, He M, Lyu X, Li H, Zhao L, Wei Z, Wang F, Zheng S, Sui J.
Li Y, et al. Among authors: wang w, wang f.
J Hematol Oncol. 2023 Jan 17;16(1):2. doi: 10.1186/s13045-023-01399-4.
J Hematol Oncol. 2023.
PMID: 36650558
Free PMC article.